Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-22-036868

Options or other derivatives

  • Chief Executive Officer acquired 827,366 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SETH SANDESH · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-07-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +827,366 827,366 D
Loading xslF345X03/ownership.xml…